2018

Jani, B. D. , Nicholl, B. I. , McQueenie, R., Connelly, D. T., Hanlon, P. , Gallacher, K. I. , Lee, D. and Mair, F. S. (2018) Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort. Europace, 20, f329-f336. (doi: 10.1093/europace/eux322) (PMID:29112751) (PMCID:PMC6277149)

Petrie, M. C. , Connelly, D. T. and Gardner, R. S. (2018) Who needs an implantable cardioverter-defibrillator? Controversies and opportunities after DANISH. European Journal of Heart Failure, 20(3), pp. 413-416. (doi: 10.1002/ejhf.1135) (PMID:29327793)

2014

Lang, N. N. , Badar, A. A., Pettit, S. J., Templeton, S., Connelly, D. T. and Gardner, R. S. (2014) Interventricular lead separation is critical for NT-proBNP reduction after cardiac resynchronization therapy. Biomarkers in Medicine, 8(6), pp. 797-806. (doi: 10.2217/BMM.13.159) (PMID:25224936)

2013

Pettit, S. J., McLean, A., Colquhoun, I., Connelly, D. and McLeod, K. (2013) Clinical experience of subcutaneous and transvenous implantable cardioverter defibrillators in children and teenagers. Pacing and Clinical Electrophysiology, 36(12), pp. 1532-1538. (doi: 10.1111/pace.12233)

Lang, N.N. and Connelly, D.T. (2013) Novel oral anticoagulants for the prevention of thromboembolism in patients with atrial fibrillation. Journal of the Royal College of Physicians of Edinburgh, 43(2), pp. 151-158. (doi: 10.4997/JRCPE.2013.213)

2012

Pettit, S. J., Petrie, M. C. , Connelly, D. T., Japp, A. G., Payne, J. R., Haj-Yahia, S. and Gardner, R. S. (2012) Use of implantable cardioverter defibrillators in patients with left ventricular assist devices. European Journal of Heart Failure, 14(7), pp. 696-702. (doi: 10.1093/eurjhf/hfs062) (PMID:22547745)

2010

Bardy, G.H. et al. (2010) An entirely subcutaneous implantable cardioverter–defibrillator. New England Journal of Medicine, 363(1), pp. 36-44. (doi: 10.1056/NEJMoa0909545)

2008

Saumarez, R.C. et al. (2008) Paced ventricular electrogram fractionation predicts sudden cardiac death in hypertrophic cardiomyopathy. European Heart Journal, 29(13), pp. 1653-1661. (doi: 10.1093/eurheartj/ehn111)

Articles

Jani, B. D. , Nicholl, B. I. , McQueenie, R., Connelly, D. T., Hanlon, P. , Gallacher, K. I. , Lee, D. and Mair, F. S. (2018) Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort. Europace, 20, f329-f336. (doi: 10.1093/europace/eux322) (PMID:29112751) (PMCID:PMC6277149)

Petrie, M. C. , Connelly, D. T. and Gardner, R. S. (2018) Who needs an implantable cardioverter-defibrillator? Controversies and opportunities after DANISH. European Journal of Heart Failure, 20(3), pp. 413-416. (doi: 10.1002/ejhf.1135) (PMID:29327793)

Lang, N. N. , Badar, A. A., Pettit, S. J., Templeton, S., Connelly, D. T. and Gardner, R. S. (2014) Interventricular lead separation is critical for NT-proBNP reduction after cardiac resynchronization therapy. Biomarkers in Medicine, 8(6), pp. 797-806. (doi: 10.2217/BMM.13.159) (PMID:25224936)

Pettit, S. J., McLean, A., Colquhoun, I., Connelly, D. and McLeod, K. (2013) Clinical experience of subcutaneous and transvenous implantable cardioverter defibrillators in children and teenagers. Pacing and Clinical Electrophysiology, 36(12), pp. 1532-1538. (doi: 10.1111/pace.12233)

Lang, N.N. and Connelly, D.T. (2013) Novel oral anticoagulants for the prevention of thromboembolism in patients with atrial fibrillation. Journal of the Royal College of Physicians of Edinburgh, 43(2), pp. 151-158. (doi: 10.4997/JRCPE.2013.213)

Pettit, S. J., Petrie, M. C. , Connelly, D. T., Japp, A. G., Payne, J. R., Haj-Yahia, S. and Gardner, R. S. (2012) Use of implantable cardioverter defibrillators in patients with left ventricular assist devices. European Journal of Heart Failure, 14(7), pp. 696-702. (doi: 10.1093/eurjhf/hfs062) (PMID:22547745)

Bardy, G.H. et al. (2010) An entirely subcutaneous implantable cardioverter–defibrillator. New England Journal of Medicine, 363(1), pp. 36-44. (doi: 10.1056/NEJMoa0909545)

Saumarez, R.C. et al. (2008) Paced ventricular electrogram fractionation predicts sudden cardiac death in hypertrophic cardiomyopathy. European Heart Journal, 29(13), pp. 1653-1661. (doi: 10.1093/eurheartj/ehn111)